Literature DB >> 18931003

Increasing prevalence and incidence of multiple sclerosis in South East Wales.

C Hirst1, G Ingram, T Pickersgill, R Swingler, D A S Compston, N P Robertson.   

Abstract

BACKGROUND AND AIMS: Epidemiological studies of multiple sclerosis suggest a trend of increasing disease prevalence in susceptible populations. The reasons for this are unclear and may be the results of methodological differences between studies, incomplete ascertainment or advances in technologies that allow the increased identification of early or mild disease. In addition, direct comparison of cross sectional prevalence estimates performed in different epochs in ethnically and geographically distinct populations may be inappropriate.
METHODS: Using detailed phenotypic information and standardised methodology, a geographically defined Welsh population was resurveyed after a significant interval, establishing contemporary prevalence rates and examining demographic and clinical data to determine causes of changing disease frequency.
RESULTS: Disease prevalence increased 45% from 101 to 146 per 100,000 population over 20 years. The greatest increase was observed in women between the ages of 45 and 54 years. No significant increase in disease frequency was observed in the male population overall, or within specific age groups. There was no demographic evidence for a pattern of earlier age at onset or diagnosis to explain increased disease frequency or decrease in mean age of the prevalent population. In addition, we failed to identify a pattern of recognition of patients with less severe disability. Although there was a modest 13% increase of 2.2 years in mean disease duration, and eight new previously prevalent patients were identified, the main cause of rising disease frequency was related to a 2.8-fold increase in disease incidence for women over 23 years from 2.65 to 7.30/100,000/year increasing the sex ratio of incident patients from 1.8 to 4.3 (women:men).
CONCLUSION: Recent change in disease incidence and prevalence in this population is likely to be the result of environmental factors that have been operative in the past few decades in women alone and infers avoidable risk factors. Modelling of current overall incidence suggests a further increase in prevalence to 260 per 100 000 population within the next 20-40 years. Further studies are needed in order to identify recent changes in sex specific environment and lifestyle that confer susceptibility.

Entities:  

Mesh:

Year:  2008        PMID: 18931003     DOI: 10.1136/jnnp.2008.144667

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Multiple sclerosis: is prevalence rising and if so why?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-11-30       Impact factor: 3.282

2.  Are the prevalence and incidence of multiple sclerosis changing?

Authors:  Julián Benito-León
Journal:  Neuroepidemiology       Date:  2011-04-20       Impact factor: 3.282

3.  Multiple sclerosis incidence in Tuscany from administrative data.

Authors:  Daiana Bezzini; L Policardo; F Profili; G Meucci; M Ulivelli; S Bartalini; P Francesconi; M A Battaglia
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

4.  Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Authors:  Margitta T Kampman; Jan Harald Aarseth; Nina Grytten; Espen Benjaminsen; Elisabeth Gulowsen Celius; Ole Petter Dahl; Trygve Holmøy; Kristin Løken-Amsrud; Rune Midgard; Kjell-Morten Myhr; Geir Risberg; Anita Vatne; Oivind Torkildsen
Journal:  J Neurol       Date:  2013-01-06       Impact factor: 4.849

Review 5.  Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.

Authors:  Jimmy L Huynh; Patrizia Casaccia
Journal:  Lancet Neurol       Date:  2013-02       Impact factor: 44.182

6.  Impact of disease-modifying therapies on the survival of patients with multiple sclerosis in Taiwan, 1997-2008.

Authors:  Ching-Piao Tsai; Charles Tzu-Chi Lee
Journal:  Clin Drug Investig       Date:  2013-09       Impact factor: 2.859

Review 7.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

8.  Geomagnetic disturbances may be environmental risk factor for multiple sclerosis: an ecological study of 111 locations in 24 countries.

Authors:  Seyed Aidin Sajedi; Fahimeh Abdollahi
Journal:  BMC Neurol       Date:  2012-09-24       Impact factor: 2.474

9.  The role of epigenetic mechanisms and processes in autoimmune disorders.

Authors:  Judith M Greer; Pamela A McCombe
Journal:  Biologics       Date:  2012-09-06

10.  Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan.

Authors:  Ching-Piao Tsai; Charles Tzu-Chi Lee
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.